Gilead said that the $11.2 billion internal R&D asset cost resulting from the acquisition in the second quarter resulted in a one-time profit and loss of approximately $9.12 per share corresponding to GAAP standards and adjusted earnings per share, including the tax impact of related transactions.

Gilead said that the $11.2 billion internal R&D asset cost resulting from the acquisition in the second quarter resulted in a one-time profit and loss of approximately $9.12 per share corresponding to GAAP standards and adjusted earnings per share, including the tax impact of related transactions.